Gilead Sciences, Inc. (GILD)
NASDAQ: GILD · Real-Time Price · USD
112.69
+2.13 (1.93%)
At close: Oct 3, 2025, 4:00 PM EDT
112.85
+0.16 (0.14%)
After-hours: Oct 3, 2025, 7:55 PM EDT
Gilead Sciences (GILD) Product Revenue by Segment
History
| Date | HIV | Oncology | Liver Disease | Other | Veklury |
|---|---|---|---|---|---|
| Jun 30, 2025 | 20.20B | 3.27B | 3.01B | 796.00M | 1.45B |
| Mar 31, 2025 | 19.86B | 3.26B | 3.04B | 874.00M | 1.55B |
| Dec 31, 2024 | 19.61B | 3.29B | 3.02B | 889.00M | 1.80B |
| Sep 30, 2024 | 18.85B | 3.21B | 2.99B | 906.00M | 2.18B |
| Jun 30, 2024 | 18.45B | 3.16B | 2.97B | 921.00M | 2.13B |
| Mar 31, 2024 | 18.33B | 3.05B | 2.85B | 884.00M | 2.17B |
| Dec 31, 2023 | 18.18B | 2.93B | 2.78B | 859.00M | 2.19B |
| Sep 30, 2023 | 18.26B | 2.78B | 2.79B | 910.00M | 2.47B |
| Jun 30, 2023 | 18.08B | 2.59B | 2.87B | 894.00M | 2.75B |
| Mar 31, 2023 | 17.68B | 2.39B | 2.84B | 907.00M | 2.94B |
| Dec 31, 2022 | 17.19B | 2.14B | 2.80B | 944.00M | 3.91B |
| Sep 30, 2022 | 16.96B | 1.88B | 2.76B | 942.00M | 4.26B |
| Jun 30, 2022 | 16.66B | 1.63B | 2.65B | 987.00M | 5.26B |
| Mar 31, 2022 | 16.37B | 1.41B | 2.76B | 1.02B | 5.64B |
| Dec 31, 2021 | 16.32B | 1.25B | 2.85B | 1.03B | 5.57B |
Source: Business metrics provided by Main Street Data and sourced
from official company press releases and documents.